Clinical Trial Update: Long-Term Analysis of DImethyl Fumarate, to Slow the Growth of Areas of Geographic Atrophy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on dimethyl fumarate to slow geographic atrophy in age-related macular degeneration; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Age-related Macular Degeneration (AMD) | Phase 2 | Status: RECRUITING